Technical note flags a short-term buy at ₹2,041, targeting ₹2,200, as the stock consolidates near support despite rising crude and a weaker rupee pressuring input costs.
A technical analysis note flagged Colgate Palmolive India as a short-term buy at ₹2,041, targeting ₹2,200 with a suggested accumulation level at ₹1,990. The call lands as the stock consolidates near support while the broader market held onto weekly gains despite a fresh spike in crude oil prices.
Brent crude climbed past $90 a barrel Monday, reaching $90.79, the highest since June 11, after the U.S. military conducted a ninth straight night of attacks against Iran. West Texas Intermediate hit $84.68. Both benchmarks extended gains from last week – Brent rose 15.9%, its biggest weekly ascent since April. The escalation also pushed the rupee to 96.28 against the dollar, its steepest weekly drop since May, as elevated oil prices and strong merchant dollar demand weighed on the currency.
For consumer staples companies like Colgate Palmolive India, higher crude and a weaker rupee raise input costs, particularly for packaging and imported raw materials. The stock's defensive characteristics and pricing power may help absorb some of that pressure. The note pointed to a potential breakout above resistance, with the next leg targeting ₹2,200.
Indian equity markets ended last week with gains, led by IT and financial stocks after upbeat results from Tech Mahindra and Jio Financial. The Nifty IT index jumped 4.34%. Bank Nifty posted a second consecutive weekly gain of 0.82%. Broader markets saw profit booking, with Nifty Realty falling 2.12%. The Union Cabinet approved the ₹1.27 lakh crore Semicon 2.0 programme, lifting semiconductor and electronics stocks.
Investors now look to a busy earnings week featuring UltraTech Cement, Infosys, Bajaj Auto, Nestle India, and SBI Life Insurance. The European Central Bank meets Thursday and is expected to hold rates at 2.25% after June's hike, with markets pricing a September move.
Colgate Palmolive shares were at ₹92.98 on the U.S. listing. The stock's Alpha Score stands at 49 out of 100, a Mixed label, reflecting a balanced risk-reward profile in the Consumer Staples sector.
Prepared with AlphaScala editorial tooling from the source reporting linked above. Indexable analysis may include a cited Alpha Score value. Publishing checks screen each story before release. Educational coverage, not personalized advice.